Novel in vitro method for identification of individuals at risk for beryllium hypersensitivity.

AUTOR(ES)

Ojo-Amaize, E A

RESUMO

Beryllium-specific lymphocytes were generated by in vitro immunization of peripheral blood mononuclear cells (PBMC) from healthy unexposed individuals. Measurement of blastogenic responses of PBMC by [3H]thymidine uptake demonstrated that sensitization of PBMC with beryllium salts followed by stimulation with unrelated salts resulted in a negative response, whereas sensitization and restimulation of PBMC with beryllium salts produced a positive response. Flow cytometric and cell depletion analyses showed that all of the responding cells were CD4+ T cells. The in vitro immunization system was used to screen 52 human subjects for susceptibility to beryllium sensitization in vitro. The results show that of the 52 healthy unexposed subjects tested, only 1 (2%) was highly responsive, 4 subjects (8%) were moderately responsive, 20 subjects (39%) were low-level responders, and 27 subjects (52%) were nonresponders. The results showing 2% high-level responsiveness to beryllium sensitization in vitro correlate with the 1 to 5% prevalence of chronic beryllium disease in individuals sensitized to beryllium dust in vivo and thus support the thesis that the in vitro immunization system may permit the identification of individuals at risk for beryllium hypersensitivity.

Documentos Relacionados

• Comparison of lymphocyte transformation and macrophage migration inhibition tests in the detection of beryllium hypersensitivity.
• Role of in vitro and in vivo tests of hypersensitivity in beryllium workers.
• Penicilloyl-polylysine intradermal testing for penicillin hypersensitivity.
• Identification of Simian virus 40 promoter DNA sequences capable of conferring restriction endonuclease hypersensitivity.
• Hypersensitivity to antigen derived from brain tissue in patients with Huntington's disease and in individuals at risk.